ALBPS.PA
Biophytis S.A.
ParisEUREQUITY
Healthcare
DELAYED
Last price
0.11
▼ 0.02 (16.03%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
0.12
Prev close
0.13
Day high
0.12
Day low
0.10
Volume
34.74M
Market cap
$14.46M
P/E (TTM)
—
52W range
0.00 – 0.21
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
313.86K
Total on file
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+37.25%
+38.6%
1M
+586.27%
+582.5%
3M
+395.28%
+392.2%
6M
+95.53%
+84.5%
YTD
+58.85%
+46.6%
1Y
-38.24%
-58.2%
3Y
-98.14%
-172.3%
5Y
-99.96%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$14.46M
Enterprise value$8.93M
Revenue (TTM)—
Gross profit—
EBITDA$-7.87M
Net income$-8.03M
EPS (TTM)$-0.41
Free cash flow$-1.64M
Total cash$1.21M
Total debt$7.72M
Book value / share$-0.33
Shares outstanding137.70M
Float23.36M
Short % of float—
Dividend yield—
Beta (5Y)0.85
Valuation & profitability ratios
Trailing P/E—
Forward P/E-0.05
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA-1.14
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on equity—
Return on assets-66.56%
Debt / equity—
Current ratio0.35
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Total revenue | — | $0 | $0 | $0 | — |
| Operating revenue | — | $0 | $0 | $0 | — |
| Cost of revenue | $0 | $0 | $0 | $0 | — |
| Gross profit | $0 | $0 | $0 | $0 | — |
| Research & development | — | $8.85M | $16.03M | $19.66M | — |
| Selling, general & admin | $5.12M | $5.49M | $7.24M | $7.15M | -6.8% |
| Total operating expense | $8.50M | $14.33M | $23.27M | $26.82M | -40.7% |
| Operating income | -$8.50M | -$14.33M | -$23.27M | -$26.82M | +40.7% |
| Net interest income | -$1.33M | -$1.41M | -$2.46M | -$2.53M | +5.8% |
| Pre-tax income | -$10.38M | -$17.03M | -$24.22M | -$31.16M | +39.0% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | — | -$17.03M | -$24.22M | -$31.16M | — |
| Net income to common | — | -$17.03M | -$24.22M | -$31.16M | — |
| Basic EPS | -2.00 | -12.54 | -55.40 | -104.00 | +84.1% |
| Diluted EPS | -2.00 | -12.54 | -55.40 | -104.00 | +84.1% |
| EBIT | -$9.61M | -$15.93M | -$23.27M | -$30.62M | +39.7% |
| EBITDA | -$9.32M | -$15.13M | -$22.79M | -$30.31M | +38.4% |
| Basic shares | 5.19M | 1.36M | 437.10K | 295.71K | +282.4% |
| Diluted shares | 5.19M | 1.36M | 437.10K | 295.71K | +282.4% |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $78.00K | $5.57M | $11.05M | $23.93M | -98.6% |
| Cash & short-term investments | $268.00K | $5.93M | $11.64M | $24.83M | -95.5% |
| Accounts receivable | $82.00K | $297.00K | $488.00K | $125.00K | -72.4% |
| Total current assets | $3.92M | $8.85M | $18.58M | $31.37M | -55.6% |
| Property, plant & equipment | $231.00K | $315.00K | $584.00K | $563.00K | -26.7% |
| Goodwill & intangibles | $2.61M | $2.64M | $2.65M | $2.76M | -1.0% |
| Total assets | $6.90M | $11.96M | $21.99M | $34.87M | -42.3% |
| Total current liabilities | $15.61M | $12.37M | $19.35M | $22.81M | +26.2% |
| Current debt | $6.48M | $3.47M | $7.48M | $8.15M | +86.9% |
| Long-term debt | — | $2.42M | $4.37M | $4.39M | — |
| Total debt | $6.61M | $6.08M | $4.37M | $12.98M | +8.8% |
| Total liabilities | $16.60M | $15.85M | $23.90M | $29.07M | +4.8% |
| Retained earnings | -$25.75M | -$19.38M | -$47.91M | -$49.01M | -32.9% |
| Shareholder equity | -$9.67M | -$3.86M | -$1.88M | $5.83M | -150.7% |
| Working capital | -$11.68M | -$3.52M | -$772.00K | $8.56M | -232.4% |
| Net tangible assets | -$12.28M | -$6.49M | -$4.53M | $3.08M | -89.1% |
| Shares issued | 7.34M | 2.60M | 595.74K | 339.88K | +182.3% |
| Line item | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|
| Net income | -$10.38M | -$17.03M | -$24.22M | -$31.16M | +39.0% |
| Depreciation & amortisation | $298.00K | $803.00K | $484.00K | $311.00K | -62.9% |
| Stock-based compensation | $739.00K | $812.00K | $5.57M | $3.42M | -9.0% |
| Change in working capital | -$583.00K | -$26.00K | -$1.33M | $1.01M | -2,142.3% |
| Operating cash flow | -$8.64M | -$12.87M | -$18.99M | -$23.80M | +32.9% |
| Capital expenditure | — | -$220.00K | -$141.00K | -$344.00K | — |
| Investing cash flow | $10.00K | $370.00K | -$17.00K | $12.16M | -97.3% |
| Dividends paid | — | $0 | $0 | $0 | — |
| Financing cash flow | $3.14M | $7.03M | $6.13M | $29.71M | -55.3% |
| Free cash flow | -$8.64M | -$13.09M | -$19.13M | -$24.14M | +34.0% |
| End cash position | $78.00K | $5.57M | $11.05M | $23.93M | -98.6% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|
| Cash & equivalents | — | $78.00K | — |
| Cash & short-term investments | — | $268.00K | — |
| Accounts receivable | — | $82.00K | — |
| Total current assets | — | $3.92M | — |
| Property, plant & equipment | — | $231.00K | — |
| Goodwill & intangibles | — | $2.61M | — |
| Total assets | — | $6.90M | — |
| Total current liabilities | — | $15.61M | — |
| Current debt | $4.58M | $6.48M | -29.2% |
| Total debt | $7.35M | $6.61M | +11.1% |
| Total liabilities | — | $16.60M | — |
| Retained earnings | — | -$25.75M | — |
| Shareholder equity | — | -$9.67M | — |
| Working capital | — | -$11.68M | — |
| Net tangible assets | — | -$12.28M | — |
| Shares issued | — | 7.34M | — |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders1.34%
Held by institutions1.38%
Institutions holding1
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.08
+29.25% from price
SMA 20
0.05
+94.57% from price
SMA 50
0.03
+241.29% from price
SMA 100
0.03
+323.15% from price
SMA 200
0.04
+143.05% from price
EMA 12
0.08
+25.50% from price
EMA 26
0.06
+81.02% from price
EMA 50
0.04
+150.63% from price
RSI (14)
70.2
Overbought
MACD (12,26,9)
0.03
Hist 0.01
ATR (14)
0.03
25.67% of price
Realised vol 30D
623.6%
Annualised
Bollinger upper
0.14
20, 2σ
Bollinger lower
-0.03
20, 2σ
50 / 200 cross
Death
0.03 vs 0.04
Trend bias
Above 200
+143.05%
Risk profile
Beta vs SPY
4.35
More volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
623.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-96.5%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.03
25.67% of price
Beta (reported)
0.85
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:400
Split dateMay 3, 2024
Headlines
Don’t Sell SanDisk Corporation (NASDAQ:SNDK) Because A Billionaire Did So, Says Jim Cramer
Insider Monkey · 16m ago
Jim Cramer Wasn’t Happy About Chevron Corporation (NYSE:CVX) Price Target Cut
Insider Monkey · 18m ago
$5,000 in Bloom Energy at Its COVID-Era Low Would Be Worth This Much Now
Motley Fool · 18m ago
Jim Cramer Wants You To Look At The Bigger Picture For Apple Inc. (NASDAQ:AAPL)
Insider Monkey · 20m ago
Jim Cramer Said NVIDIA Corp. (NASDAQ:NVDA) Doesn’t Need Anyone But Elon Musk
Insider Monkey · 21m ago
Jim Cramer Shared Insights Into Space Exploration Technologies Corp. (NASDAQ:SPCX) Short Selling
Insider Monkey · 22m ago
International Strength Offsetting North America Weakness Could Be A Game Changer For Under Armour (UAA)
Simply Wall St. · 23m ago
Jim Cramer Argued It’s A New World For Palo Alto Networks & CrowdStrike Holdings
Insider Monkey · 27m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.